MedTrace Logo

Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers

NCT07070804 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-11-21

No results posted yet for this study

Summary

This study will recruit nuMoM2b participants to complete autism screening surveys and will identify 200 children with autism and 400 controls for the study. It will then use existing biospecimens to measure pesticides in maternal urine and metabolomic urine and cord blood predictors of autism risk. All data will then be used to build a predictive model for autism risk at the child's birth.

Conditions

Interventions

OTHER

None-placebo

No interventions performed

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-08-30
Completion
2028-08-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07070804 on ClinicalTrials.gov